21 studies found for:    Ustekinumab | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Condition: Healthy
Intervention: Drug: Ustekinumab
2 Not yet recruiting A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Guselkumab;   Drug: Placebo for ustekinumab;   Drug: Placebo for guselkumab
3 Recruiting Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Interventions: Biological: Ustekinumab;   Biological: Abatacept;   Drug: Placebo for Ustekinumab;   Drug: Placebo for Abatecept
4 Recruiting Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Ustekinumab;   Other: Placebo
5 Not yet recruiting Exploratory Study on Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab
6 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
7 Not yet recruiting Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Condition: Type 1 Diabetes
Intervention: Drug: Ustekinumab
8 Recruiting Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Conditions: CVID;   Enteropathy;   Chronic Diarrhea;   Maldigestion;   Malabsorption
Intervention: Biological: Ustekinumab
9 Recruiting Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
10 Not yet recruiting Ustekinumab for Active Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Ustekinumab
11 Recruiting The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
Condition: Psoriasis
Intervention: Drug: Ustekinumab
12 Recruiting Swiss Dermatology Network of Targeted Therapies (SDNTT)
Condition: Psoriasis
Interventions: Biological: Adalimumab;   Biological: Etanercept;   Biological: Infliximab;   Biological: Ustekinumab;   Drug: Cyclosporine A;   Drug: Fumaric acids;   Drug: Methotrexate;   Drug: Other anti-psoriatic systemic treatments
13 Recruiting Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Condition: Chronic Plaque Type Psoriasis
Interventions: Drug: secukinumab 300 mg;   Drug: ustekinumab 45/90 mg sc and placebo secukinumab
14 Recruiting Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Conditions: Psoriasis;   Pregnancy
Intervention:
15 Recruiting BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
Condition: Psoriasis
Interventions: Drug: BI 655066;   Drug: Ustekinumab
16 Recruiting Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Condition: Psoriasis
Interventions: Drug: etanercept;   Drug: ustekinumab;   Drug: cyclosporine
17 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
18 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
19 Recruiting Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
Conditions: Psoriasis;   Atherosclerosis
Intervention: Drug: biological treatment
20 Recruiting Evaluation of Vitamin D Levels in Psoriasis Patients
Condition: Psoriasis
Interventions: Other: Topical Therapy;   Other: Phototherapy and Systemic Therapy;   Other: Biologic Therapy

Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results
Indicates status has not been verified in more than two years